The American Journal of Medicine
Volume 103, Issue 6 , Pages 462-467 , December 1997

Upper Gastrointestinal Adverse Events and Cyclical Etidronate

  • Tjeerd van Staa MD

      Affiliations

    • Procter & Gamble Pharmaceuticals, Lovett House, Lovett Road, Staines, United Kingdom
    • ,
  • Lucien Abenhaim MD

      Affiliations

    • Department of Epidemiology and Biostatistics, McGill University Montreal, Canada
    • Center for Clinical Epidemiology and Community Studies, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Canada
    • Corresponding Author InformationL Abenhaim, MD, Center for Clinical Epidemiology and Community Studies, Sir Mortimer B. Davis-Jewish General Hospital, 3755, chemin de la Co̊te-Ste-Catherine, Montreal, Canada H3T 1E2.
    • ,
  • Cyrus Cooper MD

      Affiliations

    • Medical Research Council Environmental Epidemiology Unit, Southampton University Hospital, Southampton, United Kingdom

Received 14 January 1997 ,Accepted 21 May 1997.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This work was supported by Procter & Gamble Pharmaceuticals.

PII: S0002-9343(97)00242-8

The American Journal of Medicine
Volume 103, Issue 6 , Pages 462-467 , December 1997

Article Tools

* Image Usage & Resolution